ZNF263 Activators
ZNF263, also known as Zinc Finger Protein 263, belongs to the Krüppel-like zinc finger protein family, which plays essential roles in transcriptional regulation and chromatin organization. ZNF263 is a transcription factor that contains multiple C2H2-type zinc finger motifs, allowing it to bind to specific DNA sequences and modulate gene expression. The primary function of ZNF263 is to regulate the transcription of target genes by acting as a transcriptional activator or repressor, depending on the context of its binding sites within the genome. Through its interactions with other transcriptional regulators and chromatin-modifying enzymes, ZNF263 participates in diverse biological processes, including cell proliferation, differentiation, and development.
Activation of ZNF263 involves intricate regulatory mechanisms that control its transcriptional activity and DNA-binding specificity. One potential mechanism of activation is through post-translational modifications, such as phosphorylation, acetylation, or SUMOylation, which can modulate the stability, subcellular localization, and DNA-binding affinity of ZNF263. Additionally, ZNF263 activity may be regulated by signaling pathways activated by extracellular stimuli, such as growth factors or cytokines, which converge on downstream kinases or phosphatases that directly or indirectly target ZNF263 or its cofactors. Furthermore, ZNF263 activity may be influenced by interactions with other transcription factors or cofactors, forming regulatory complexes that modulate its ability to bind to specific DNA sequences and regulate target gene expression. Understanding the intricate mechanisms governing ZNF263 activation provides insights into its role in transcriptional regulation and its impact on cellular processes and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A, an endocrine disruptor, interacts with estrogen receptors, leading to the modification of transcription factor activity. ZNF263 is a transcription factor that binds to specific DNA sequences; hence, changes in the estrogen receptor pathway may enhance the DNA-binding activity of ZNF263, altering transcriptional regulation of target genes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC can initiate a signaling cascade that leads to the phosphorylation of transcription factors. Phosphorylation of ZNF263 might alter its conformation or interaction with co-factors, thereby enhancing its DNA-binding activity and downstream gene transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn activates PKA. PKA phosphorylation can enhance the activity of transcription factors by modifying their interaction with co-regulatory proteins. Phosphorylation by PKA may enhance ZNF263’s ability to regulate gene expression by altering its DNA binding or interaction with transcriptional machinery. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a histone deacetylase inhibitor, similar to Trichostatin A, leading to an open chromatin structure. This could potentially enhance the DNA binding of ZNF263 to its target gene promoters, thus increasing ZNF263-mediated gene transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, an active metabolite of vitamin A, acts through its nuclear receptors to regulate gene expression. It can modulate the transcription factor landscape of a cell. ZNF263 activity could be enhanced by retinoic acid through changes in chromatin accessibility or by influencing other transcription factors that co-operate with ZNF263 in gene regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit DNA methyltransferases, leading to reduced methylation of cytosine bases in DNA. This hypomethylation could improve the binding affinity of transcription factors like ZNF263 to DNA, potentially enhancing its activity in regulating gene expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
17-beta-Estradiol, the primary female sex hormone, binds to estrogen receptors and can modify transcription factor dynamics. As ZNF263 is a transcription factor, its activity could be influenced by the altered transcriptional programs induced by 17-beta-Estradiol, possibly enhancing ZNF263's functional activity in gene regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which can alter the activity of AP-1 transcription factors. As ZNF263 is a Krüppel-associated box (KRAB) zinc finger protein involved in transcriptional repression, inhibition of JNK may lead to changes in transcriptional regulation that enhance the repressive activities of ZNF263 on its target genes. | ||||||